Proteus International, SmithKline Beecham Biologicals S.A. deal

SmithKline terminated a non-exclusive worldwide license to Proteus' nonionic surfactant vesicles (NISV) vaccine adjuvant technology. Proteus said the termination wasn't financially significant to the ...